BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsuo Y. A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer. Technol Cancer Res Treat 2018;17:1533033818798633. [PMID: 30198413 DOI: 10.1177/1533033818798633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Le Tinier F, Padovani L, Vandendorpe B. Traitements par radiothérapie stéréotaxique : indications et situations cliniques particulières. Revue des Maladies Respiratoires Actualités 2021;13:2S81-2S88. [DOI: 10.1016/s1877-1203(21)00101-4] [Reference Citation Analysis]
2 Christensen TN, Langer SW, Persson G, Larsen KR, Loft A, Amtoft AG, Berthelsen AK, Johannesen HH, Keller SH, Kjaer A, Fischer BM. 18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial. J Nucl Med 2021;62:628-35. [PMID: 33037090 DOI: 10.2967/jnumed.120.247742] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Christensen TN, Langer SW, Persson G, Larsen KR, Amtoft AG, Keller SH, Kjaer A, Fischer BM. Impact of [18F]FDG-PET and [18F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics (Basel) 2021;11:279. [PMID: 33670242 DOI: 10.3390/diagnostics11020279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yamazaki H, Suzuki G, Aibe N, Nakamura S, Yoshida K, Oh R; JReRT Group. A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan. J Radiat Res 2021;62:285-93. [PMID: 33341887 DOI: 10.1093/jrr/rraa112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Atalar B, Mustafayev TZ, Sio TT, Sahin B, Gungor G, Aydın G, Yapici B, Ozyar E. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors. Radiol Oncol 2020;54:480-7. [PMID: 32589607 DOI: 10.2478/raon-2020-0039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kowalchuk RO, Waters MR, Richardson KM, Spencer KM, Larner JM, Kersh CR. Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer. Pract Radiat Oncol 2020;10:e475-84. [PMID: 32454175 DOI: 10.1016/j.prro.2020.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Robinson DG, Snow S, Brade A, Ho C, Wheatley-price P, Blais N, Cheema P, Swaminath A. Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations. Cancer Treatment and Research Communications 2020;25:100265. [DOI: 10.1016/j.ctarc.2020.100265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wink KCJ, Löck S, Rossi M, van Baardwijk A, Belderbos J, de Ruysscher D, Troost EGC. Contact of a tumour with the pleura is not associated with regional recurrence following stereotactic ablative radiotherapy for early stage non-small cell lung cancer. Radiother Oncol 2019;131:120-6. [PMID: 30773178 DOI: 10.1016/j.radonc.2018.11.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]